Targeting stromal cells may help overcome treatment resistance in glioblastoma
The deadly brain cancer glioblastoma is often resistant to chemotherapy and radiation, but new research from the Perelman School of Medicine and the Abramson Cancer Center shows targeting stromal cells—the cells that serve as the connective tissue of the organs—may be an effective way of overcoming that resistance.
FULL STORY AT Penn Medicine News →